The Tumor Necrosis Factor Inhibitor Drugs Market in North America is experiencing steady growth, supported by advanced healthcare systems, increasing diagnosis of autoimmune disorders, and strong adoption of biologic therapies. The region benefits from ongoing pharmaceutical research, favorable reimbursement frameworks, expanding biosimilar availability, and growing awareness of early...